AR029004A1 - Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana - Google Patents

Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana

Info

Publication number
AR029004A1
AR029004A1 ARP000104904A ARP000104904A AR029004A1 AR 029004 A1 AR029004 A1 AR 029004A1 AR P000104904 A ARP000104904 A AR P000104904A AR P000104904 A ARP000104904 A AR P000104904A AR 029004 A1 AR029004 A1 AR 029004A1
Authority
AR
Argentina
Prior art keywords
preparation
antibacterial composition
group
heteroariltio
ceboem
Prior art date
Application number
ARP000104904A
Other languages
English (en)
Original Assignee
Essential Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essential Therapeutics Inc filed Critical Essential Therapeutics Inc
Publication of AR029004A1 publication Critical patent/AR029004A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Un compuesto del ácido 7-acilamino-3-heteroariltio-3-cefem carboxílico que posee la formula química: 1 o una sal farmacéuticamente aceptable del mismo, en donde: R'1 se selecciona del grupo que consiste de hidrogeno y ûC (O) CH (NH2) CH3; R'2 es hidrogeno o un grupo acilo que es dividido por una enzima encontrada en los mamíferos, B o L es nitrogeno y el otro es carbono; y, Q es seleccionado del grupo que consiste de nitrogeno y ûCX, en donde X se selecciona del grupo que consiste de hidrogeno y cloro. Uso de un compuesto del ácido 7-acilamino-3-heteroariltio-3-cefem carboxílico o sal del mismo para la preparacion de una composicion antibacteriana para tratar un mamífero que padece una infeccion bacteriana causada por Staphylococco resistente a la meticilina.
ARP000104904A 1999-09-22 2000-09-19 Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana AR029004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15549699P 1999-09-22 1999-09-22

Publications (1)

Publication Number Publication Date
AR029004A1 true AR029004A1 (es) 2003-06-04

Family

ID=22555673

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104904A AR029004A1 (es) 1999-09-22 2000-09-19 Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana

Country Status (24)

Country Link
EP (1) EP1222194B1 (es)
JP (1) JP2003509512A (es)
KR (1) KR20020068508A (es)
CN (1) CN1206231C (es)
AR (1) AR029004A1 (es)
AT (1) ATE297934T1 (es)
AU (1) AU784077B2 (es)
BR (1) BR0014230A (es)
CA (1) CA2385479A1 (es)
CZ (1) CZ2002993A3 (es)
DE (1) DE60020862D1 (es)
HK (1) HK1048121B (es)
HU (1) HUP0202663A3 (es)
IL (2) IL148669A0 (es)
MX (1) MXPA02003024A (es)
MY (1) MY136038A (es)
NO (1) NO20021416L (es)
NZ (1) NZ517761A (es)
PL (1) PL354919A1 (es)
RU (1) RU2225868C2 (es)
SK (1) SK4122002A3 (es)
TW (1) TWI283682B (es)
WO (1) WO2001021623A1 (es)
ZA (1) ZA200202065B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534656B2 (en) 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
ATE449775T1 (de) * 2003-04-30 2009-12-15 Trine Pharmaceuticals Inc Carbacephem beta-lactam-antibiotika
CN111187281B (zh) * 2020-02-11 2023-03-14 广西科技大学 含胍基的头孢菌素衍生物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA18891A1 (fr) * 1979-07-05 1981-04-01 Ciba Geigy Ag Composes d'amino-thiadiazolyle,procede pour leur preparation
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
WO1992005156A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Pyridylthio or pyridyloxy alkanoic acids
NZ284212A (en) * 1994-04-01 1997-11-24 Microcide Pharmaceuticals Inc Cephalosporin antibiotics; antibacterial medicament
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
WO1996038450A1 (en) * 1995-05-31 1996-12-05 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
JP4174093B2 (ja) * 1998-01-09 2008-10-29 富士フイルムファインケミカルズ株式会社 トリアゾール誘導体ハロゲン化合物の製造方法
WO1999058535A1 (en) * 1998-05-13 1999-11-18 Lg Chemical Ltd. Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same

Also Published As

Publication number Publication date
NO20021416D0 (no) 2002-03-21
TWI283682B (en) 2007-07-11
PL354919A1 (en) 2004-03-22
EP1222194A1 (en) 2002-07-17
ATE297934T1 (de) 2005-07-15
HK1048121B (zh) 2005-11-04
ZA200202065B (en) 2007-11-28
HUP0202663A3 (en) 2003-10-28
MXPA02003024A (es) 2003-09-25
IL148669A (en) 2006-04-10
IL148669A0 (en) 2002-09-12
EP1222194B1 (en) 2005-06-15
JP2003509512A (ja) 2003-03-11
RU2225868C2 (ru) 2004-03-20
CZ2002993A3 (cs) 2002-07-17
CN1451011A (zh) 2003-10-22
WO2001021623A1 (en) 2001-03-29
NZ517761A (en) 2003-10-31
BR0014230A (pt) 2002-05-21
HUP0202663A2 (hu) 2002-12-28
CA2385479A1 (en) 2001-03-29
MY136038A (en) 2008-08-29
AU784077B2 (en) 2006-02-02
NO20021416L (no) 2002-05-22
HK1048121A1 (en) 2003-03-21
CN1206231C (zh) 2005-06-15
AU7709500A (en) 2001-04-24
KR20020068508A (ko) 2002-08-27
DE60020862D1 (de) 2005-07-21
SK4122002A3 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
EA200100623A1 (ru) Кетолидные антибиотики
BR9802851A (pt) Antibióticos de macrolìdeo substituìdos por c-4
SE9904508D0 (sv) New compounds
EA200501098A1 (ru) Антибактериальные агенты
MXPA03005464A (es) Agentes antivirales.
EA199901016A1 (ru) 9-оксим-производные эритромицина
EA200100396A1 (ru) Новые макролидные антибиотики
EA200100983A1 (ru) Производные 13-метилэритромицина
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
ATE291021T1 (de) Oxytocin agonisten
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ES2096933T3 (es) Compuesto capaz de permanecer en la region intracerebral y utilizacion del mismo.
ES2156633T3 (es) Derivados del acido tiazolidina-4-carboxilico como agentes citoprotectores.
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
ES2178301T3 (es) Derivados del acido penicilanico 2-beta-sustituido-6-alquilideno como inhibidores de la beta-lactama.
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
EA200001029A1 (ru) Производные гигромицина
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
RS50033B (sr) Derivati etansulfonil-piperidina
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
BR0015153A (pt) Derivados de higromicina
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel
EP1057829A4 (en) Condensed pyrimidine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FA Abandonment or withdrawal